Conference
A RANDOMIZED, CONTROLLED PHASE 2 CLINICAL TRIAL OF JX-594, A TARGETED MULTI-MECHANISTIC ONCOLYTIC POXVIRUS, IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: FINAL DATA
Authors
Heo J; Reid T; Ruo L; Bloomston M; Lim HY; Chung HC; Kim CW; Rose SC; Rhee B-G; Patt RH
Volume
54
Pagination
pp. 1426A-1426A
Publisher
WILEY-BLACKWELL
Publication Date
October 1, 2011
Name of conference
62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)
Conference place
San Francisco, CA
Conference start date
November 4, 2011
Conference end date
November 8, 2011
Conference proceedings
HEPATOLOGY
ISSN
0270-9139